H3K27-ALTERED HIGH GRADE GLIOMA

Clinical trials for H3K27-ALTERED HIGH GRADE GLIOMA explained in plain language.

Never miss a new study

Get alerted when new H3K27-ALTERED HIGH GRADE GLIOMA trials appear

Sign up with your email to follow new studies for H3K27-ALTERED HIGH GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with devastating brain cancer

Disease control Recruiting now

This study is testing an oral medication called ACT001 in children and young adults with two types of aggressive brain tumors: diffuse intrinsic pontine glioma (DIPG) and H3K27-altered high-grade glioma (HGG). The main goals are to see if the drug is safe and if it helps patients…

Matched conditions: H3K27-ALTERED HIGH GRADE GLIOMA

Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

H3K27-ALTERED HIGH GRADE GLIOMA

Get alerted when new H3K27-ALTERED HIGH GRADE GLIOMA trials appear

New hope for kids with devastating brain cancer